Annual Shareholders Equity
-$373.85 M
-$91.39 M-32.35%
December 1, 2023
Summary
- As of February 22, 2025, MAZE annual stockholders equity is -$373.85 million, with the most recent change of -$91.39 million (-32.35%) on December 1, 2023.
- During the last 3 years, MAZE annual shareholders equity has fallen by -$91.39 million (-32.35%).
Performance
MAZE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
-$284.53 M
-$22.16 M-8.45%
September 1, 2024
Summary
- As of February 22, 2025, MAZE quarterly stockholders equity is -$284.53 million, with the most recent change of -$22.16 million (-8.45%) on September 1, 2024.
- Over the past year, MAZE quarterly shareholders equity has dropped by -$22.16 million (-8.45%).
Performance
MAZE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MAZE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.4% | -8.4% |
| 3 y3 years | -32.4% | -8.4% |
| 5 y5 years | -32.4% | -8.4% |
MAZE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +32.4% | at low | +8.4% | +31.4% |
| 5 y | 5-year | +32.4% | at low | +8.4% | +31.4% |
| alltime | all time | +32.4% | at low | +8.4% | +31.4% |
Maze Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$284.53 M(+8.4%) |
| Jun 2024 | - | -$262.37 M(-29.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$373.85 M(+32.4%) | -$373.85 M |
| Dec 2022 | -$282.46 M | - |
FAQ
- What is Maze Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Maze Therapeutics?
- What is Maze Therapeutics annual shareholders equity year-on-year change?
- What is Maze Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Maze Therapeutics?
- What is Maze Therapeutics quarterly shareholders equity year-on-year change?
What is Maze Therapeutics annual stockholders equity?
The current annual shareholders equity of MAZE is -$373.85 M
What is the all time high annual shareholders equity for Maze Therapeutics?
Maze Therapeutics all-time high annual stockholders equity is -$282.46 M
What is Maze Therapeutics annual shareholders equity year-on-year change?
Over the past year, MAZE annual stockholders equity has changed by -$91.39 M (-32.35%)
What is Maze Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MAZE is -$284.53 M
What is the all time high quarterly shareholders equity for Maze Therapeutics?
Maze Therapeutics all-time high quarterly stockholders equity is -$262.37 M
What is Maze Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, MAZE quarterly stockholders equity has changed by -$22.16 M (-8.45%)